Vigilant Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-200
| Closed | -$34K | – | 566 |
|
|
2021
Q4 | $34K | Hold |
200
| – | – | ﹤0.01% | 352 |
|
|
2021
Q3 | $38K | Hold |
200
| – | – | ﹤0.01% | 290 |
|
|
2021
Q2 | $34K | Hold |
200
| – | – | ﹤0.01% | 300 |
|
|
2021
Q1 | $28K | Hold |
200
| – | – | ﹤0.01% | 273 |
|
|
2020
Q4 | $26K | Hold |
200
| – | – | ﹤0.01% | 266 |
|
|
2020
Q3 | $29K | Hold |
200
| – | – | ﹤0.01% | 254 |
|
|
2020
Q2 | $30K | Hold |
200
| – | – | ﹤0.01% | 235 |
|
|
2020
Q1 | $22K | Hold |
200
| – | – | ﹤0.01% | 250 |
|
|
2019
Q4 | $23K | Hold |
200
| – | – | ﹤0.01% | 377 |
|
|
2019
Q3 | $16K | Hold |
200
| – | – | ﹤0.01% | 329 |
|
|
2019
Q2 | $15K | Hold |
200
| – | – | ﹤0.01% | 334 |
|
|
2019
Q1 | $19K | Sell |
200
-300
| -60% | -$28.5K | ﹤0.01% | 330 |
|
|
2018
Q4 | $36K | Hold |
500
| – | – | 0.01% | 277 |
|
|
2018
Q3 | $44K | Hold |
500
| – | – | 0.01% | 282 |
|
|
2018
Q2 | $49K | Hold |
500
| – | – | 0.01% | 257 |
|
|
2018
Q1 | $60K | Hold |
500
| – | – | 0.01% | 215 |
|
|
2017
Q4 | $64K | Hold |
500
| – | – | 0.01% | 205 |
|
|
2017
Q3 | $59K | Buy |
500
+300
| +150% | +$35.4K | 0.01% | 173 |
|
|
2017
Q2 | $16K | Hold |
200
| – | – | ﹤0.01% | 225 |
|
|
2017
Q1 | $10K | Hold |
200
| – | – | ﹤0.01% | 247 |
|
|
2016
Q4 | $7K | Buy |
200
+100
| +100% | +$3.5K | ﹤0.01% | 258 |
|
|
2016
Q3 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 275 |
|
|
2014
Q1 | – | Sell |
-450
| Closed | -$29K | – | 268 |
|
|
2013
Q4 | $29K | Buy |
+450
| New | +$29K | 0.01% | 184 |
|